Skip to search formSkip to main contentSkip to account menu

CS 526

Known as: CS-526, CS526 cpd 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
New pharmaceutical use
The invention provides the competitive sour retarding agent (P CAB) of potassium to be used to treating, prevent and/or… 
2007
2007
Pharmacological Profile of Novel Acid Pump Antagonist 7-(4-Fluorobenzyloxy)-2,3-dimethyl-1-{[(1S,2S)-2-methyl cyclopropyl]methyl}-1H-pyrrolo[2,3-d]pyridazine (CS-526)
The pharmacological profiles of the novel acid pump antagonist 7-(4-fluorobenzyloxy)-2,3-dimethyl-1-{[(1S,2S)-2-methylcyclopropyl… 
2004
2004
Purification and Characterization of a Novel Class IIa Bacteriocin , Piscicocin CS 526 , from Surimi-Associated Carnobacterium piscicola CS 526
The bacteriocin piscicocin CS526 was inactivated by proteolytic enzymes, was stable at 100°C for 30 min, had a pH range of 2 to 8… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)